Methods for determining illness, progression to death, and/or timing of death of biological entity

• US 7,136,697 B2
• Filed: 05/17/2005
• Issued: 11/14/2006
• Est. Priority Date: 05/03/2001
• Status: Active Grant

• Current Assignee: The Nutrition Solutions Corporation
• Original Assignee: Michaeal G. Singer
• Inventors: Singer, Michaeal G.
• Primary Examiner(s): HOANG, TU BA
• Application Number:
  US10/908,567
• Publication Number:
  US 20050209527A1
• Time in Patent Office: 546 Days
• Field of Search: 600/300, 600384-386, 600/506, 600/536, 600546-547, 600/587, 128/898, 439/586, 324/600, 324/713
• US Class Current: 600/547
• CPC Class Codes: A61B 5/053 Measuring electrical impedance or conductance of a portion of the body
• CPC Class Codes: A61B 5/0537 Measuring body composition by impedance, e.g. tissue hydration or fat content
• CPC Class Codes: A61B 5/416 the spleen
• CPC Class Codes: A61B 5/4869 Determining body composition
• CPC Class Codes: G01N 33/48707 by electrical means G01N33/49, G01N33/493 take precedence

Abstract

A method for determining illness of a biological entity, progression to non-acute death of the biological entity, and/or timing of non-acute death of the biological entity. A comparison of measured values of resistance, reactance, phase angle, extracellular and intracellular water volumes, and membrane status of whole body and regions of the entity show hallmarks of the state of health of the entity.

Claims

1. A method for determining illness of a biological entity, progression to non-acute death of said biological entity, or timing of non-acute death of said biological entity, comprising the steps of:

providing normal values of resistance, reactance, phase angle, extracellular water volume, intracellular water volume, and membrane status of whole body and regions of said biological entity;

measuring initial values of resistance, reactance, phase angle, extracellular water volume, intracellular water volume, and membrane status of whole body and regions of said biological entity;

taking whole body and regional measurements of resistance, reactance, phase angle, extracellular water volume, intracellular water volume, and membrane status at predetermined intervals of time;

recording said whole body and regional measurements;

comparing initial values of said whole body or regional measurements to said normal values of said whole body or regional measurements, respectively, and to serially measured values of said whole body or regional measurements, respectively; and

determining from said comparison steps hallmarks of said illness of said biological entity, said progression to said non-acute death of said biological entity, or said timing of non-acute death of said biological entity.

2. A method according to claim 1, wherein:

said hallmarks include an uncorrectable loss of cell mass and membrane capacitance as evidenced by a reduction in said reactance and phase angle.

3. A method according to claim 1, wherein:

said hallmarks include an uncorrectable and increasing disparity of said extracellular water volume being greater than said intracellular water volume.

4. A method according to claim 2, wherein:

said hallmarks include an uncorrectable and increasing disparity of said extracellular water volume being greater than said intracellular water volume.

5. A method according to claim 2, wherein:

when said uncorrectable loss of cell mass and membrane capacitance remains uncorrectable, said uncorrectable loss of cell mass and membrane capacitance comprise hallmarks of said progression of said non-acute death of said biological entity.

6. A method according to claim 4, wherein:

when said uncorrectable loss of cell mass and membrane capacitance remains uncorrectable, said uncorrectable loss of cell mass and membrane capacitance comprise hallmarks of said progression of said non-acute death of said biological entity.

7. A method according to claim 3, wherein:

when said uncorrectable and increasing disparity of said extracellular water volume being greater than said intracellular water volume remains uncorrectable, said uncorrectable and increasing disparity of said extracellular water volume comprise hallmarks of said progress to said non-acute death of said biological entity.

8. A method according to claim 4, wherein:

when said uncorrectable and increasing disparity of said extracellular water volume being greater than said intracellular water volume remains uncorrectable, said uncorrectable and increasing disparity of said extracellular water volume comprise hallmarks of said progress to said non-acute death of said biological entity.

9. A method according to claim 6, wherein:

when said uncorrectable and increasing disparity of said extracellular water volume being greater than said intracellular water volume remains uncorrectable, these are hallmarks of said progression to said non-acute death of said biological entity.

10. A method according to claim 1, wherein:

values of said phase angle less than approximately four degrees denote serious illness of said biological entity; and

values of said phase angle less than approximately two degrees denote imminent death of said biological entity.

11. A method according to claim 2, wherein:

values of said phase angle less than approximately four degrees denote serious illness of said biological entity; and

values of said phase angle less than approximately two degrees denote imminent death of said biological entity.

12. A method according to claim 3, wherein:

values of said phase angle less than approximately four degrees denote serious illness of said biological entity; and

values of said phase angle less than approximately two degrees denote imminent death of said biological entity.

13. A method according to claim 4, wherein:

values of said phase angle less than approximately four degrees denote serious illness of said biological entity; and

values of said phase angle less than approximately two degrees denote imminent death of said biological entity.

14. A method according to claim 5, wherein:

values of said phase angle less than approximately four degrees denote serious illness of said biological entity; and

values of said phase angle less than approximately two degrees denote imminent death of said biological entity.

15. A method according to claim 6, wherein:

values of said phase angle less than approximately four degrees denote serious illness of said biological entity; and

values of said phase angle less than approximately two degrees denote imminent death of said biological entity.

16. A method according to claim 7, wherein:

values of said phase angle less than approximately four degrees denote serious illness of said biological entity; and

values of said phase angle less than approximately two degrees denote imminent death of said biological entity.

17. A method according to claim 8, wherein:

values of said phase angle less than approximately four degrees denote serious illness of said biological entity; and

values of said phase angle less than approximately two degrees denote imminent death of said biological entity.

18. A method according to claim 9, wherein:

values of said phase angle less than approximately four degrees denote serious illness of said biological entity; and

values of said phase angle less than approximately two degrees denote imminent death of said biological entity.

19. A method according to claim 1, wherein:

a slowly decreasing ohm value of said reactance is indicative of a negative or catabolic metabolism condition; and

a more precipitous and rapid decrease in said reactance is indicative of unique conditions which rapidly affect cells and their membranes.

20. A method for determining illness of a biological entity, progression to non-acute death of said biological entity, or timing of non-acute death of said biological entity, comprising the steps of:

providing normal values of resistance, reactance, phase angle, extracellular water volume, intracellular water volume, and membrane status of whole body and regions of said biological entity;

measuring initial values of resistance, reactance, phase angle, extracellular water volume, intracellular water volume, and membrane status of whole body and regions of said biological entity;

taking whole body and regional measurements of resistance, reactance, phase angle, extracellular water volume, intracellular water volume, and membrane status at predetermined intervals of time;

recording said whole body and regional measurements;

comparing initial values of said whole body or regional measurements to said normal values of said whole body or regional measurements, respectively, and to serially measured values of said whole body or regional measurements, respectively;

determining from said comparison steps hallmarks of said illness of said biological entity, said progression to said non-acute death of said biological entity, or said timing of non-acute death of said biological entity; and

said whole body and/or regional measurements of said resistance, said reactance, said phase angle, said extracellular water volume, and said intracellular water volume are taken every other day or as frequently as required to illustrate changes in said whole body and/or regional measurements over time and to illuminate disease progression and response to treatment.

21. A method for determining illness of a biological entity, progression to non-acute death of said biological entity, or timing of non-acute death of said biological entity, comprising the steps of:

providing normal values of resistance, reactance, phase angle, extracellular water volume, intracellular water volume, and membrane status of whole body and regions of said biological entity;

measuring initial values of resistance, reactance, phase angle, extracellular water volume, intracellular water volume, and membrane status of whole body and regions of said biological entity;

taking whole body and regional measurements of resistance, reactance, phase angle, extracellular water volume, intracellular water volume, and membrane status at predetermined intervals of time;

recording said whole body and regional measurements;

comparing initial values of said whole body or regional measurements to said normal values of said whole body or regional measurements, respectively, and to serially measured values of said whole body or regional measurements, respectively;

determining from said comparison steps hallmarks of said illness of said biological entity, said progression to said non-acute death of said biological entity, or said timing of non-acute death of said biological entity;

said hallmarks include an uncorrectable loss of cell mass and membrane capacitance as evidenced by a reduction in said reactance and phase angle; and

said whole body and/or regional measurements of said resistance, said reactance, said phase angle, said extracellular water volume, and said intracellular water volume are taken every other day or as frequently as required to illustrate changes in said whole body and/or regional measurements over time and to illuminate disease progression and response to treatment.